Genotype based evaluation of Pseudomonas aeruginosa eradication treatment success in cystic fibrosis patients

Journal of Cystic Fibrosis

Volumn 9, Issue 2, 2010, Pages 99-103

  Schelstraete, Petra ^a   Deschaght, Pieter ^b   Van Simaey, Leen ^b   Van daele, Sabine ^a   Haerynck, Filomeen ^a   Vaneechoutte, Mario ^b   De Baets, Frans ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Eradication treatment efficacy; Genotyping; P. aeruginosa

Indexed keywords

CIPROFLOXACIN; COLISTIN; TOBRAMYCIN;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIUM DETECTION; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE FREE INTERVAL; DRUG EFFICACY; DRUG TREATMENT FAILURE; ERADICATION THERAPY; FEMALE; GENETIC SIMILARITY; GENOTYPE; HUMAN; INFANT; MALE; MICROBIAL MORPHOLOGY; NONHUMAN; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY TRACT INFECTION; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; GENOTYPE; HUMANS; INFANT; LONGITUDINAL STUDIES; MALE; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 76749139465     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2009.11.006     Document Type: Article

References (24)

1. Means M.B., Hunt G.H., and Rushworth R. Bacterial flora of respiratory tract in patients with cystic fibrosis, 1950-71. Arch Dis Child 47 (1972) 902-907
2. Høiby N. Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis. Acta Pathol Microbiol Scand [B] Microbiol Immunol 82 (1974) 541-550
3. FitzSimmons S. The cystic fibrosis patient registry report. Pediatr Pulmonol 21 (1996) 267-275
4. Kosorok M.R., Zeng L., West S.E., Rock M.J., Splaingard M.L., Laxova A., et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 32 (2001) 277-287
5. Nixon G.M., Armstrong D.S., Carzino R., Carlin J.B., Olinsky A., Robertson C.F., et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 138 (2001) 699-704
6. Kerem E., Corey M., Gold R., and Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr 116 (1990) 714-719
7. Henry R.L., Mellis C.M., and Petrovic L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol 12 (1992) 158-161
8. Fitzsimmons S. The changing epidemiology of cystic fibrosis. J Pediatr 122 (1993) 1-9
9. Valerius N.H., Koch C., and Høiby N. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 338 (1991) 725-726
10. Vasquez C., Municio M., Corera M., Gaztelurrutia L., Sojo A., and Vitoria J.C. Early treatment of Pseudomonas aeruginosa colonisation in cystic fibrosis. Acta Paediatr Scand 82 (1993) 308-309
11. Frederiksen B., Koch C., and Høiby N. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients. Pediatr Pulmonol 28 (1999) 159-166
12. Frederiksen B., Koch C., and Høiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 23 (1997) 330-335
13. Jones A.M., Dodd M.E., Govan J.R., Doherty C.J., Smith C.M., Isalska B.J., et al. Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center. Am J Respir Crit Care Med 171 (2005) 257-260
14. Scott F.W., and Pitt T.L. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J Med Microbiol 53 (2004) 609-615
15. Van daele S., Vaneechoutte M., De Boeck K., Knoop C., Malfroot A., Lebecque P., et al. Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients. Eur Respir J 28 (2006) 740-747
16. Munck A., Bonacorsi S., Mariani-Kurkdjian P., Lebourgeois M., Gérardin M., Brahimi N., et al. Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization. Pediatr Pulmonol 32 (2001) 288-292
17. Taccetti G., Campana S., Festini F., Mascherini M., and Döring G. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients. Eur Respir J 26 (2005) 458-461
18. Hansen C.R., Pressler T., and Høiby N. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. J Cyst Fibros 7 (2008) 523-530
19. Döring G., Høiby N., and for the Consensus Study Group. Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. J Cyst Fibros 3 (2004) 67-91
20. Döring G., Conway S.P., Heijerman H.G., Hodson M.E., Høiby N., Smyth A., et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 16 (2000) 749-767
21. Vaneechoutte M., Boerlin P., Tichy H.V., Bannerman E., Jager B., and Bille J. Comparison of PCR-based DNA fingerprinting techniques for the identification of Listeria species and their use for atypical Listeria isolates. Int J Syst Bacteriol 48 (1998) 127-139
22. Baele M., Baele P., Vaneechoutte M., Storms V., Butaye P., Devriese L.A., et al. Application of tRNA intergenic spacer PCR for identification of Enterococcus species. J Clin Microbiol 38 (2000) 4201-4207
23. Tramper-Stranders G., van der Ent C., and Wolfs T. Detection of Pseudomonas aeruginosa in patients with cystic fibrosis. J Cyst Fibros 4 Suppl 2 (2005 Aug) 37-43
24. Schelstraete P., Van Daele S., De Boeck K., Proesmans M., Lebecque P., Leclercq-Foucart J., et al. Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients. Eur Respir J 31 (2008) 822-829